BeStock  
Stocks › PVLA

Palvella Therapeutics PVLA

US equityMarket cap rank #2815
$132.16 −$0.31 (-0.23%)
Market closed · Oct 6, 4:50 am ET · Last extended-hours $132.00 -0.12%
Open$132.50
Prev close$132.47
Day range$129.51 – $133.27
Volume142.9K
Market cap$1.90B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership107.9%-1.36 pts vs. prior quarter
Institutions holding239-1 vs. prior quarter
Insider trades (recent)34 buys / 15 sellsNet buying
Short interest16.14% of floatDays to cover 12.8 · as of 15 Sep 2026
Short-sale volume share26.9%5-day average of daily volume

Short-sale volume as % of daily volume

15%24%32%40%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$3.17M (8 inflow days, 12 outflow days).

The five largest holders on file together own 32.8% of shares outstanding.

Largest holders

  • Montanova Capital, LLC7.88%
  • Jennison Associates LLC6.67%
  • BlackRock6.37%
  • Frazier Life Sciences Management, LP6.12%
  • Wesley Kaupinen5.73%
  • First Light Asset Management, LLC5.36%
  • BVF Partners L.P.4.67%
  • State Street Global Advisors4.53%

By investor type

  • Mutual Fund62.89%
  • Hedge Fund19.98%
  • VC/PE Fund14.92%
  • Individual/Insider8.01%
  • Private Company4.26%
  • Public Company3.46%
  • Sovereign Wealth Fund1.85%
  • Government Pension Fund0.26%

Reported short interest has fallen from 16.50% to 16.14% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 2,325,699 16.1% 12.8
31 Aug 2026 2,291,288 15.9% 11.1
14 Aug 2026 2,149,544 14.9% 12.8
31 Jul 2026 2,068,268 14.4% 9.2
15 Jul 2026 2,177,331 15.2% 9.2
30 Jun 2026 2,366,341 16.5% 6.3

Discussion

No comments yet — be the first to weigh in on PVLA.

Leave a comment

Scroll to Top